Company: NIVFW
Filing Date: 2025-09-18
Form Type: F-1
Source: 0001213900-25-088927
Chunk: 93

Company: NewGenIvf Group Ltd
Filing Date: 2025-09-18
Form: F-1
Chunk 93
---
, or the current applicable regulations may otherwise be amended or replaced
requiring the assisted reproductive medical facilities in its network to conduct business with additional oversight and regulatory compliance.
If NewGenIvf fails to obtain the necessary licenses, permits and approvals, NewGenIvf may be subject to fines, confiscation of revenues
generated from incompliance operations, or the suspension of relevant operations. NewGenIvf may also experience adverse publicity arising
from such non-compliance with government regulations that negatively impacts its brand. NewGenIvf may experience difficulties or failures
in obtaining the necessary approvals, licenses, and permits for new spaces or new service offerings. If NewGenIvf fails to obtain the
material licenses, NewGenIvf’s business activities could be severely delayed. In addition, there can be no assurance that NewGenIvf
will be able to obtain, renew, and/or convert all of the approvals, licenses, and permits required for its existing business operations
upon their expiration in a timely manner, in a cost-efficient manner or at all, which could adversely affect NewGenIvf’s business
operations and financial condition.

In addition, considerable
uncertainties exist in relation to the interpretation and implementation of existing and future laws and regulations governing NewGenIvf’s
business activities. NewGenIvf could be found not in compliance with any future laws and regulations or of the laws and regulations currently
in effect due to changes in the relevant authorities’ interpretation of those laws and regulations. It is possible that different
interpretations or enforcement of these regulations could subject the current or past practices to allegations of impropriety or illegality
or require the medical facilities in its network to implement changes in the facilities, equipment, personnel or services, or increase
capital expenditure and operating expenses. If NewGenIvf fails to complete, obtain, or maintain any of the required licenses or approvals
or make the necessary filings, NewGenIvf may be subject to various penalties, such as confiscation of unlawful gains, the imposition
of fines, revocation of licenses, and the discontinuation or restriction of NewGenIvf’s operations. Any such penalties or changes
in policies, regulations, or enforcement by government authorities may disrupt NewGenIvf’s operations and materially and adversely
affect NewGenIvf’s business, financial condition, and results of operations.

<div align='center'>51</div>

Legal or regulatory restriction, government regulation, industry standards and other requirements create risks and challenges with respect to NewGenI